Theranostic Advances in Breast Cancer in Nuclear Medicine

被引：52
|
作者：
Vahidfar, Nasim [1 ]
Aghanejad, Ayuob [2 ]
Ahmadzadehfar, Hojjat [3 ]
Farzanehfar, Saeed [1 ]
Eppard, Elisabeth [4 ,5 ]
机构：
[1] Univ Tehran Med Sci, Vali Asr Hosp, Dept Nucl Med, Tehran 1419733141, Iran
[2] Tabriz Univ Med Sci, Biomed Inst, Res Ctr Pharmaceut Nanotechnol, Tabriz 51368, Iran
[3] Klinikum Westfalen, Dept Nucl Med, D-44149 Dortmund, Germany
[4] Positronpharma SA, Rancagua 878, Santiago 7500621, Chile
[5] Univ Hosp Magdeburg, Dept Nucl Med, Leipziger Str 44, D-39120 Magdedurg, Germany
来源：
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2021年 / 22卷 / 09期
关键词：
theranostic; radiopharmaceutical; imaging; therapy; GASTRIN-RELEASING-PEPTIDE; NEUROENDOCRINE TUMORS; BOMBESIN RECEPTORS; PET; EXPRESSION; DIAGNOSIS; SUBTYPES; FIBROBLASTS; LIGANDS; PATIENT;
D O I：
10.3390/ijms22094597
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
The implication of 'theranostic' refers to targeting an identical receptor for diagnostic and therapeutic purposes, by the same radioligand, simultaneously or separately. In regard to extensive efforts, many considerable theranostic tracers have been developed in recent years. Emerging evidence strongly demonstrates the tendency of nuclear medicine towards therapies based on a diagnosis. This review is focused on the examples of targeted radiopharmaceuticals for the imaging and therapy of breast cancer.
引用
收藏
页数：17
相关论文
共 50 条
  • [1] Nuclear medicine advances in breast cancer imaging
    Bombardieri, E
    Crippa, F
    Baio, SM
    Peeters, BAM
    Greco, M
    Pauwels, EK
    TUMORI JOURNAL, 2001, 87 (05): : 277 - 287
  • [2] Metastatic Heterogeneity of Breast Cancer: Companion and Theranostic Approach in Nuclear Medicine
    Montemagno, Christopher
    Pages, Gilles
    CANCERS, 2020, 12 (04)
  • [3] Advances in Preclinical Research of Theranostic Radiopharmaceuticals in Nuclear Medicine
    Hu, Mei
    Zhang, Chenshuo
    Fan, Dandan
    Yang, Ru
    Bai, Yongxiang
    Shi, Haibin
    ACS APPLIED MATERIALS & INTERFACES, 2025, 17 (03) : 4337 - 4353
  • [4] Potential of PSMA for breast cancer in nuclear medicine: digital quantitative immunohistochemical analysis and implications for a theranostic approach
    Neviere, Zoe
    Blanc-Fournier, Cecile
    Guizard, Anne-Valerie
    Elie, Nicolas
    Giffard, Florence
    Lequesne, Justine
    Emile, George
    Poulain, Laurent
    Lasnon, Charline
    BMC CANCER, 2024, 24 (01)
  • [5] Theranostic and nanotheranostic probes in nuclear medicine
    Drude, Natascha
    Tienken, Lena
    Mottaghy, Felix M.
    METHODS, 2017, 130 : 14 - 22
  • [6] Theranostic in Nuclear Medicine - The paradigm of NET
    Giammarile, Francesco
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2023, 26 : 42 - 43
  • [7] Nuclear medicine imaging of breast cancer
    VanEijck, CHJ
    Krenning, EP
    Kvols, LK
    NUCLEAR MEDICINE COMMUNICATIONS, 1996, 17 (11) : 925 - 927
  • [8] Nuclear Medicine in the diagnosis of breast cancer
    Giannoula, Evanthia
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2014, 17 (03): : 220 - 227
  • [9] Insights into the theranostic value of precision medicine on advanced radiotherapy to breast cancer
    Jiang, Man
    Yang, Jianshe
    Li, Kang
    Liu, Jia
    Jing, Xigang
    Tang, Meiqin
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2021, 18 (03): : 626 - 638
  • [10] Precision medicine for breast cancer: advances and challenges
    Liu, Xin-Yi
    Yu, Tian-Jian
    Shao, Zhi-Ming
    TRANSLATIONAL BREAST CANCER RESEARCH, 2024, 5
12345